Page last updated: 2024-12-05

isoquinoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Isoquinoline is a heterocyclic aromatic organic compound with the formula C9H7N. It is a colorless liquid with a pungent odor. It is structurally similar to quinoline, but with the nitrogen atom in a different position. Isoquinoline is a key building block for many natural products, including alkaloids, and is also used in the synthesis of pharmaceuticals and dyes. Isoquinoline is found in coal tar and is produced by the reaction of aniline with formaldehyde. It is also a component of tobacco smoke. Isoquinoline has been shown to have a number of biological effects, including antibacterial, antifungal, and anti-inflammatory activity. It is also a known mutagen and carcinogen. Isoquinoline is studied because of its potential applications in medicine and industry. It is also a subject of study because of its environmental impact.'

Cross-References

ID SourceID
PubMed CID8405
CHEMBL ID12315
CHEBI ID16092
SCHEMBL ID9654
SCHEMBL ID4543153
SCHEMBL ID8569035
SCHEMBL ID6506458
MeSH IDM0117290

Synonyms (76)

Synonym
.beta.-quinoline
nsc-3395
nsc3395
wln: t66 cnj
2-azanaphthalene
isochinolin
CHEBI:16092 ,
ai3-10035
nsc 3395
fema no. 2978
3,4-benzopyridine
isochinolin [czech]
einecs 204-341-8
beta-quinoline
benzo(c)pyridine
ccris 5752
AC-907/25014235
RTE3_000001
PK04_181276
inchi=1/c9h7n/c1-2-4-9-7-10-6-5-8(9)3-1/h1-7
119-65-3
benzo[c]pyridine
2-benzazine
C06323
isoquinoline ,
ISQ ,
isoquinoline, 97%
DB04329
isoquinoline, technical grade, 90-92%
8-(1,4-diazepan-1-ylsulfonyl)isoquinoline
2-benzanine
CHEMBL12315
I0182
AKOS000119148
A804333
NCGC00188120-01
cas-119-65-3
NCGC00256872-01
tox21_302503
dtxsid2047644 ,
dtxcid0027644
BBL011362
STL146455
unii-jgx76y85m6
ec 204-341-8
jgx76y85m6 ,
FT-0627506
isoquinoline [fhfi]
isoquinoline [mi]
SCHEMBL9654
mfcd00006898
PS-5337
isoquinolin
SCHEMBL4543153
SCHEMBL8569035
SCHEMBL6506458
CS-W013448
W-108502
bdbm60921
isoquinoline, analytical standard
F0001-0310
2-azanaphthalene; 2-benzazine; benzo[c]pyridine; benzopyridine; nsc 3395; ?-quinoline
beta -quinoline
fema 2978
BCP23537
Q412316
isoquinoline-5,8-d2
SY246282
mfcd31699977
2241982-85-2
BCP27363
AMY38996
F52665
HY-W012732
EN300-19121
Z104472854

Research Excerpts

Overview

Isoquinoline alkaloids are a large class of natural products with a broad range of biological activities. They have antimicrobial, antitumor, antileukemic and anti-inflammatory properties.

ExcerptReferenceRelevance
"Isoquinoline alkaloids are a large class of natural products with a broad range of biological activities, including antimicrobial, antitumor, antileukemic and anti-inflammatory properties. "( Novel Biosynthetic Route to the Isoquinoline Scaffold.
Kolling, D; Luzhetskyy, A; Myronovskyi, M; Nadmid, S; Paulus, C; Rosenkränzer, B; Shuai, H; Stierhof, M, 2022
)
2.45

Effects

ExcerptReferenceRelevance
"Isoquinoline has been identified as a component of coal tar which causes interfollicular regions of parakeratotic stratum corneum in mouse tail epidermis to become orthokeratotic, with concomitant production of a granular layer. "( Isoquinoline is a possible anti-psoriatic agent in coal tar.
Clark, C; Devitt, H; Foreman, MI; Hanlon, G; Kelly, I; Lukowiecki, G; Taylor, M, 1985
)
3.15

Toxicity

ExcerptReferenceRelevance
" Nine isoquinolines and MPP(+) showed general cytotoxicity in both parental cell lines after 72hr with half-maximal toxic concentrations (TC(50) values) in the micromolar range."( Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
Frenzel, S; Hein, A; Hwang, YI; Matsubara, K; Ohta, S; Ortmann, R; Ott, S; Schwarz, J; Storch, A; Wolf, HU, 2002
)
1.06
" In this review, the toxic components and their toxicological mechanisms of some toxic CMM were listed according to the chemical structure classification of toxic components."( The Toxicity and Attenuation Methods of Toxic Chinese Materia Medica for its Reasonable Application: A Review.
Chi, YY; Han, JX; Xiang, H; Xiang, JY; Xie, Q, 2021
)
0.62

Bioavailability

ExcerptReferenceRelevance
" Compound 9l, which was orally bioavailable in mice and guinea pigs, showed in vivo efficacy after oral administration in a bronchial asthma model of guinea pigs."( Isoquinoline derivatives as potent, selective, and orally active CRTH2 antagonists.
Asakura, Y; Kawamura, M; Kawanishi, M; Nishikawa-Shimono, R; Sekiguchi, Y; Takaoka, A; Takayama, T; Wakasugi, D; Watanabe, K, 2014
)
1.85
" Optimization of the sulfonamide substituent has provided compounds with a very desirable overall profile, including minimal hERG activity, good bioavailability and in vivo efficacy."( 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile.
Belanoff, JK; Golding, E; Gourdet, B; Hunt, HJ; Phillips, T; Swift, D; Thomas, J; Unitt, JF; Walters, I, 2015
)
0.71
" Further SAR exploration and optimization led to the discovery of potent B-Raf(V600E) inhibitors with good oral bioavailability in rats and dogs."( Discovery of EBI-907: A highly potent and orally active B-Raf(V600E) inhibitor for the treatment of melanoma and associated cancers.
Cao, H; Cao, J; Hu, Q; Huang, S; Liu, D; Lu, B; Shen, R; Shen, X; Tao, W; Wan, H; Wang, D; Yan, Y; Yang, L; Zhang, J; Zhang, L; Zhang, M, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
"beta cells in islets of Langerhans were studied in Sprague-Dawley rats dosed by gavage with 0 (control), 75, 150, 250 or 300 mg/kg body wt/day S-H 966 BS [1-(1-oxido-4-thiomorpholino)-3-(1-piperazinyl)], an isoquinoline derivative."( Cytoplasmic vacuolation of pancreatic beta cells of rats after oral administration of a derivative of isoquinoline.
Kast, A; Ueberberg, H, 1986
)
0.67
" We confirmed their bioactivity mechanism in vitro, developed soluble prodrugs, and established safe in vivo dosing in mice."( Isoquinoline-based biaryls as a robust scaffold for microtubule inhibitors.
Ahlfeld, J; Bracher, F; Gao, L; Glas, C; Heise, C; Kraus, Y; Melzer, B; Preuße, M; Thorn-Seshold, O, 2020
)
2
"5-24 h) and dose-response (25-100 mg/kg, 10 ml/kg, intragastrically) curves of MAO activity inhibition using adult C57Bl/6 male mice."( Dopaminergic system contribution to the antidepressant-like effect of 3-phenyl-4-(phenylseleno) isoquinoline in mice.
Bilheri, FN; Nogueira, CW; Sampaio, TB; Zeni, GR, 2020
)
0.78
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (4)

ClassDescription
isoquinolinesA class of organic heteropolycyclic compound consisting of isoquinoline and its substitution derivatives.
mancude organic heterobicyclic parent
azaarene
ortho-fused heteroareneAn ortho-fused compound in which at least one of the rings contains at least one heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (22)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency76.95880.006038.004119,952.5996AID1159521
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency23.31860.001530.607315,848.9004AID1224841; AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency68.58960.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency1.09640.000229.305416,493.5996AID743075
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency30.63790.000627.21521,122.0200AID743202
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Ki100.00000.00020.656110.0000AID40666
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Ki100.00000.00020.656110.0000AID40666
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Ki100.00000.00020.656110.0000AID40666
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Ki100.00000.00020.561410.0000AID40666
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Ki100.00000.00020.635210.0000AID40666
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Ki100.00000.00020.621710.0000AID40666
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Ki100.00000.00020.675810.0000AID40666
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Ki100.00000.00020.646910.0000AID40666
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Ki100.00000.00020.656110.0000AID40666
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Ki100.00000.00020.656110.0000AID40666
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Ki100.00000.00020.671210.0000AID40666
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Ki100.00000.00020.557710.0000AID40666
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Ki100.00000.00020.640310.0000AID40666
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Ki100.00000.00020.570810.0000AID40666
GABA theta subunitRattus norvegicus (Norway rat)Ki100.00000.00020.656110.0000AID40666
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Ki100.00000.00020.656110.0000AID40666
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (8)

Processvia Protein(s)Taxonomy
nicotinamide metabolic processNicotinamide N-methyltransferaseHomo sapiens (human)
response to xenobiotic stimulusNicotinamide N-methyltransferaseHomo sapiens (human)
response to organonitrogen compoundNicotinamide N-methyltransferaseHomo sapiens (human)
animal organ regenerationNicotinamide N-methyltransferaseHomo sapiens (human)
methylationNicotinamide N-methyltransferaseHomo sapiens (human)
NAD biosynthesis via nicotinamide riboside salvage pathwayNicotinamide N-methyltransferaseHomo sapiens (human)
positive regulation of gluconeogenesisNicotinamide N-methyltransferaseHomo sapiens (human)
positive regulation of protein deacetylationNicotinamide N-methyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
nicotinamide N-methyltransferase activityNicotinamide N-methyltransferaseHomo sapiens (human)
pyridine N-methyltransferase activityNicotinamide N-methyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
cytosolNicotinamide N-methyltransferaseHomo sapiens (human)
cytosolNicotinamide N-methyltransferaseHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (26)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID266771Permeability in human skin2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID266765Effective permeability coefficient in 70% silicon-30% IPM membrane2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID1145387Partition coefficient, log P of the compound by HPLC analysis1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Direct measurement of octanol-water partition coefficients by high-pressure liquid chromatography.
AID61002The maximum dopamine release induced by perfusion with the test compound with basal striatal DA (%of basal x10E-3)1990Journal of medicinal chemistry, Aug, Volume: 33, Issue:8
In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.
AID1145386Partition coefficient, log P of the compound by shake-flask technique1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Direct measurement of octanol-water partition coefficients by high-pressure liquid chromatography.
AID61001The maximal DA release induced by perfusion with 10 mM MPP+ (15 min) 1 day after perfusion with the test compound with basal striatal DA (%of basal x10E-3)1990Journal of medicinal chemistry, Aug, Volume: 33, Issue:8
In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.
AID311367Permeability coefficient in human skin2007Bioorganic & medicinal chemistry, Nov-15, Volume: 15, Issue:22
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
AID25367Compound was evaluated for the pKa value in water at 20 degrees Centigrade1995Journal of medicinal chemistry, Dec-22, Volume: 38, Issue:26
In vitro antimalarial activity of chalcones and their derivatives.
AID1367487Lipophilicity, log P of the compound2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Improvement in aqueous solubility achieved via small molecular changes.
AID40666In vitro inhibition of [3H]diazepam binding to benzodiazepine receptor in rat cerebral cortical membrane1982Journal of medicinal chemistry, Sep, Volume: 25, Issue:9
Beta-carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors.
AID343680Hexadecane-water distribution coefficient, log D at pH 7.4 by shake-flask technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID551809Displacement of Y-27632 from ROCK-1 assessed as drop in intensity of binding signals by NMR competition experiment2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors.
AID343398Octanol-water distribution coefficient, log D at pH 7.4 by shake-flask technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID310931Partition coefficient, log P of the compound2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
AID266764Membrane permeability, CA(t)/CD(0) in 70% silicon-30% IPM membrane2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID310933Permeability across PAMPA membrane after 7 hrs2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
AID1182519Radioprotective activity against gamma-irradiated human MOLT4 cells preincubated for 1 hr at 100 to 400 uM before gamma-irradiation measured after 18 hrs by erythrosine B dye-exclusion test2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Design and synthesis of 8-hydroxyquinoline-based radioprotective agents.
AID1367493Solubility of the compound2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Improvement in aqueous solubility achieved via small molecular changes.
AID310932Permeability across human Skin2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID266766Dissociation constant, pKa of the compound2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID266763Membrane retention in 70% silicon-30% IPM membrane2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
AID1802032NNMT Enzymatic Activity Assay from Article 10.1021/acs.biochem.6b00733: \\A Rapid and Efficient Assay for the Characterization of Substrates and Inhibitors of Nicotinamide N-Methyltransferase.\\2016Biochemistry, 09-20, Volume: 55, Issue:37
A Rapid and Efficient Assay for the Characterization of Substrates and Inhibitors of Nicotinamide N-Methyltransferase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (386)

TimeframeStudies, This Drug (%)All Drugs %
pre-199062 (16.06)18.7374
1990's18 (4.66)18.2507
2000's83 (21.50)29.6817
2010's180 (46.63)24.3611
2020's43 (11.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 66.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index66.73 (24.57)
Research Supply Index5.99 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index112.16 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (66.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews22 (5.54%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other375 (94.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]